Molecular Research of Cardiomyopathy
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 31 January 2025 | Viewed by 72
Special Issue Editors
2. Laboratory of Molecular, Cellular and Ultrastructural Pathology, IRCCS San Raffaele Roma, 00166 Rome, Italy
Interests: molecular pathology; autophagy; heart disease; cellular pathology; sirtuins; cell death; electron microscopy
Special Issues, Collections and Topics in MDPI journals
2. Laboratory of Molecular, Cellular and Ultrastructural Pathology, IRCCS San Raffaele Roma, 00166 Rome, Italy
Interests: molecular pathology; autophagy; heart disease; cellular pathology; sirtuins; cell death; electron microscopy
Special Issue Information
Dear Colleagues,
Cardiomyopathies are a diverse group of diseases that impair heart function. Primary cardiomyopathies specifically affect the myocardium and can have genetic causes, such as hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and mitochondrial cardiomyopathy. They can also result from both genetic and acquired factors, as seen in dilated cardiomyopathy (DCM) and restrictive cardiomyopathy (RCM). Advances in genomics have identified common mutations associated with these conditions, and in vitro and in vivo studies of these mutations have provided critical insights into their molecular mechanisms. Additionally, increased access to genetic testing has made it easier to identify potential inherited risk factors, which may only become apparent in the later stages of these diseases. Contributions to this Special Issue will provide insights into new mechanisms that broadly contribute to cardiomyopathies of various etiologies and will propose therapeutic interventions to tackle emerging challenges in heart health.
Dr. Luigi Sansone
Dr. Manuel Belli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiomyopathy
- heart failure
- hypertrophic cardiomyopathy
- cellular and molecular rehabilitation
